Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| BridgeBio Pharma, Inc.(BBIO) | 5,089,611 | 4,589,611 | -500,000 | $377.95M | $341.83M | 72.48% | -$36.12M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 1,555,664 | 1,555,664 | 0 | $25.59M | $37.65M | 7.98% | +$12.06M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 1,316,806 | 1,316,806 | 0 | $30.76M | $28.79M | 6.10% | -$1.98M |
| COMPASS Pathways plc(CMPS) | 1,432,336 | 1,432,336 | 0 | $7.92M | $20.27M | 4.30% | +$12.35M |
| BICARA THERAPEUTICS INC | 568,919 | 568,919 | 0 | $11.32M | $16.89M | 3.58% | +$5.58M |
| BRIDGEBIO ONCOLOGY THERAPEUT | 1,018,018 | 1,018,018 | 0 | $9.11M | $7.76M | 1.64% | -$1.35M |
| Scholar Rock Holding Corporation(SRRK) | 77,031 | 77,031 | 0 | $3.79M | $4.24M | 0.90% | +$449.9K |
| UroGen Pharma Ltd.(URGN) | 108,000 | 108,000 | 0 | $1.94M | $3.97M | 0.84% | +$2.03M |
| BIOMEA FUSION INC | 2,048,757 | 2,048,757 | 0 | $3.13M | $3.01M | 0.64% | -$122.9K |
| ACLARIS THERAPEUTICS INC | 434,455 | 434,455 | 0 | $1.63M | $2.30M | 0.49% | +$669.1K |
| EUPRAXIA PHARMACEUTICALS INC | 325,000 | 325,000 | 0 | $2.35M | $2.15M | 0.46% | -$204.8K |
| VTV THERAPEUTICS INC | 0 | 50,000 | +50,000 | $0 | $1.88M | 0.40% | +$1.88M |
| MARKER THERAPEUTICS INC | 325,370 | 325,370 | 0 | $423.0K | $478.3K | 0.10% | +$55.3K |
| ONKURE THERAPEUTICS INC | 88,607 | 88,607 | 0 | $366.8K | $404.0K | 0.09% | +$37.2K |